triazolam has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iketani, O; Kawamura, S; Okamoto, S; Ueda, T; Yamaguchi, M; Yamayoshi, Y | 1 |
Ikarashi, N; Ishii, M; Kon, R; Kusunoki, Y; Machida, Y; Ochiai, W; Sugiyama, K; Toda, T | 1 |
2 other study(ies) available for triazolam and imatinib mesylate
Article | Year |
---|---|
Suicide attempt with an overdose of imatinib.
Topics: Antineoplastic Agents; Azepines; Benzamides; Drug Overdose; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Middle Aged; Piperazines; Pyrimidines; Suicide, Attempted; Triazolam | 2012 |
Total gastrectomy may result in reduced drug effectiveness due to an increase in the expression of the drug-metabolizing enzyme Cytochrome P450, in the liver.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Basal Metabolism; Benzamides; Body Weight; Cytochrome P-450 Enzyme System; Eating; Gastrectomy; Imatinib Mesylate; Intestine, Large; Intestine, Small; Liver; Male; Mice; Mice, Inbred ICR; Microsomes, Liver; Piperazines; Pyrimidines; Triazolam | 2014 |